In recent months a number of deals, acquisitions, service and product launches have led to a growing discussion around the mobile health opportunities for pharma companies. There seem to be three big ones vying for the top.
Is it adding connectivity to clinical trials?
Earlier this month research analyst firm Cutting Edge Information (CEI) published a report that suggested pharma companies look...
London-based Exco InTouch, which is providing Pfizer with the mobile clinical trial technology its using in its REMOTE study, has secured about $4.67 million from Scottish Equity Partners (SEP). Exco plans to use the funds to expand and take advantage of the "significant growth opportunities" in the emerging mobile patient communication market, the company's press release stated.
Exco claims to...
